Shed advertises NAD+ in injection, nasal-spray, and tablet formats. CoreAge’s NAD offer presents injection and nasal options. That makes route selection the first useful distinction between the two services.
CoreAge is our featured commercial partner. The comparison does not treat more formats as proof of better care or a lower entry price as proof of better value; the selected product and clinical plan still need to match.
Shed adds a prescription tablet option. Compare the route-specific offer and evidence rather than treating its lowest starting price as the cost of every format.
Shed’s tablet option changes the comparison
A prescription tablet is a different product from a home injection and from a retail NR or NMN capsule. Ask what ingredient, formulation, and instructions apply to the particular Shed tablet. Do not infer its evidence from a study of an unrelated oral precursor.
If a tablet is the main reason for your interest, the Shed review and supplements versus injections guide help distinguish retail shopping from a clinical prescription route.
Keep the lowest price attached to its format
Shed’s public page starts at $144 and offers multiple routes. A general starting figure should not be presented as the price of every injection, tablet, or nasal plan. Request the exact route-specific total and renewal terms.
CoreAge also has different public starting figures across pages. Its review identifies the discrepancy so that the comparison can use the selected offer rather than the lowest number found anywhere on the site.
Nasal convenience does not establish the same outcome
Both services advertise a nasal option. That may be relevant for a reader who wants to discuss a needle-free prescription, but the delivery route alone cannot establish superior absorption, brain effects, or clinical benefit.
The nasal versus injection comparison examines the evidence boundary. Ask each clinician why the proposed route fits the question you brought to the evaluation and what would trigger reassessment.
A route change may affect more than the price
If you later want to switch formats, ask whether a new evaluation is required, how pending orders are handled, and whether the original product can be returned. The pharmacy may have already committed an order before the next shipment appears in a portal.
Storage and beyond-use instructions also change with the preparation. Do not carry instructions from a nasal bottle to a vial or from a tablet to another oral product.
Choose the comparison that matches your priority
For prescription tablets, Shed’s public offering is a distinct point to investigate. For injection or nasal care, compare the selected prescription, clinician access, pharmacy, total cost, and renewal conditions directly.
Neither a larger catalog nor CoreAge’s commercial placement establishes that a particular route works better. A useful decision begins with a clear product identity and a clinical explanation of the proposed plan.
Sources & reading notes
Editorial source review updated September 19, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- Shed: NAD+ routes and prices Provider lists nasal spray from $144/month and injections or oral tablets from $169/month. Checked September 18, 2026.
- CoreAge Rx: current NAD+ offer Provider advertising; offer page displays $99/month. Checked September 19, 2026.
- CoreAge Rx: NAD+ Nasal Provider description of a different administration route.
- FDA: compounding questions and answers Explains that compounded drugs are not FDA-approved.
- FDA: questions and answers on dietary supplements Regulatory categories and limits of premarket review.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.
